1
|
Ibekwe TS, Rogers C, Nnodu O, Ramma L. Protocol for a comparative cross-sectional study on characterisation of auditory impairment in sickle cell disease and sickle cell trait and its impact on health-related quality of life in Nigeria. BMJ Open 2024; 14:e077200. [PMID: 38286692 PMCID: PMC10826583 DOI: 10.1136/bmjopen-2023-077200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Accepted: 12/06/2023] [Indexed: 01/31/2024] Open
Abstract
INTRODUCTION Sickle cell disease (SCD) and sickle cell traits (SCT) are genetically inherited red blood cell disorders common among people of African descent. Nigeria has a high prevalence of SCD, with a prevalence of 2.28%-3% and SCT, 25%-30%. Poorly managed SCD and SCT can lead to sensorineural hearing loss and health-related quality of life (HRQoL) issues. This research aims to assess these possible complications of SCD and SCT in Nigeria. METHODS AND ANALYSIS The study will use a comparative cross-sectional design at study power 80% to investigate the association between SCD/SCT, hearing impairment and HRQoL. Participants will be divided into two groups: a cohort and a control group. Hearing levels will be assessed through audiometric assessments and categorised by type and severity of hearing impairments using WHO classifications. HRQoL will also be assessed using WHO Disability Assessment Schedule 2.0. Statistical analyses will be performed using the SAS V.9.4, with parametric or non-parametric analysis depending on the distribution. Relationship between key variables will be determined via correlational tests, χ2, Fisher's exact test and multivariable logistic regression analyses. ETHICS AND DISSEMINATION The proposal has been fully reviewed and registered by the University of Cape Town's Faculty of Health Sciences Human Research Ethics Committee (HREC REF 228/2022) and the University of Abuja Teaching Hospital Human Research Ethics Committee (HREC/PR/2020/08/007). Information dissemination will be through conferences, peer-review publication and personal communications. The Strengthening the Reporting of Observational Studies in Epidemiology statement will be followed in writing the manuscript.
Collapse
Affiliation(s)
- Titus S Ibekwe
- Department of Otorhinolaryngology, University of Abuja, Abuja, Nigeria
- Division of Communication Sciences and Disorders, Department of Health and Rehabilitation Sciences, University of Cape Town Faculty of Health Sciences, Observatory, South Africa
| | - Christine Rogers
- Division of Communication Sciences and Disorders, Department of Health and Rehabilitation Sciences, University of Cape Town Faculty of Health Sciences, Observatory, South Africa
| | - Obiageli Nnodu
- Centre of Excellence for Sickle Cell Disease Research & Training (CESRTA), University of Abuja, Abuja, Nigeria
| | - Lebogang Ramma
- Division of Communication Sciences and Disorders, Department of Health and Rehabilitation Sciences, University of Cape Town Faculty of Health Sciences, Observatory, South Africa
| |
Collapse
|
2
|
Nelson MD, Bennett DM, Lehman ME, Okonji AI. Dizziness, Falls, and Hearing Loss in Adults Living With Sickle Cell Disease. Am J Audiol 2022; 31:1178-1190. [DOI: 10.1044/2022_aja-22-00059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Objective:
The aim of this study was to assess the prevalence of reported dizziness/imbalance, frequency of falls, and hearing loss in adults with sickle cell disease (SCD) and determine the relationship of these self-reported problems both during and in the absence of an SCD crisis. Also, the impact of educational level and health insurance on seeking treatment services, as well as the relationship of falls to stroke, legal blindness, and other orthopedic problems, was assessed. Interrupted blood flow to shared vestibular and auditory arteries supports the notion of increased likelihood of balance deficits and increased falls in this population.
Design:
A cross-sectional survey study design was used. Adults living with SCD responded to a questionnaire that was distributed online and through traditional mail.
Study Sample:
Adults living with SCD (
N
= 135) participated in the study.
Results:
Responses revealed 70% of participants with SCD experienced dizziness/imbalance and 23% reported hearing loss. Furthermore, 33% of participants reported falling one or more times in the last year. The prevalence of dizziness/imbalance, falling, and hearing loss in the respondents with SCD was much higher than that of the general population of the United States. Additionally, for dizziness and falling, the prevalence was higher not only than the national average but also for persons over 65 years of age. A significant association was demonstrated between dizziness/imbalance and hearing loss as well as dizziness/imbalance and falls for adults living with SCD. In fact, participants with self-reported hearing loss were 5.2 times more likely to also report dizziness/imbalance. They were 4.9 times more likely to fall if they also reported dizziness/imbalance. Numbness of the feet was revealed to significantly impact the likelihood of falling in this disease population and should be further studied. Regarding SCD crisis status, dizziness/imbalance and falls were more likely to occur outside of SCD crisis than during a crisis. Furthermore, pain levels were significantly associated with dizziness/imbalance only when respondents were in crisis and not in the absence of a crisis. In crisis, higher pain levels were reported from respondents who also reported dizziness/imbalance than from those who did not report dizziness. No significant relationship was revealed between hearing loss and falls.
Discussion:
These results provide justification for patient and health care provider education regarding appropriate referrals for vestibular/balance assessments and provision of fall prevention strategies. Future studies on balance and SCD are encouraged.
Collapse
|
3
|
Tantawy AAG, Ibrahim SW, Abdel-Aziz TT, Rabie AN, Makkeyah SM, Ragab IA. Inner Ear Complications in Children and Adolescents with Sickle Cell Disease. Hemoglobin 2020; 44:411-417. [PMID: 33164572 DOI: 10.1080/03630269.2020.1837863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Hearing impairment is a reported complication of sickle cell disease, yet inner ear pathology is not fully understood. The study purpose was to examine the patterns of inner ear involvement in patients with sickle cell disease by magnetic resonance imaging (MRI) and to assess its association with auditory functions. A cross-sectional study included 22 children with sickle cell disease examined for inner ear pathology by audiogram, MRI inner ear and transcranial Doppler (TCD) with revision of their hospital records for transfusion, chelation and hydroxyurea (HU) therapy. Abnormal MRI in the form of intrinsic T1 hyperintensity within the lumen of inner ear structures and cochlear neuropathy was found in five (22.7%) patients; left middle cerebral artery (MCA) flow velocity was higher in patients with abnormal MRI (83.4 ± 5.3 cm/sec) compared to normal MRI (68.2 ± 11.1 cm/sec) (p = 0.015), however, none of the patients had TCD of >170 cm/sec. There was no significant difference between patients with normal and abnormal MRI as regards hearing level and speech audiometry. Sensorineural hearing loss (SNHL) was present in two (9.1%) and conductive hearing loss (CHL) in two (9.1%) patients. There was a significant negative correlation between right ear mean hearing level and right MCA flow velocity and significant negative correlation between left ear mean hearing level and basilar artery (BA) flow velocity. We concluded that inner ear pathology is not uncommon in asymptomatic patients with sickle cell anemia, yet it did not correlate with hearing impairment and may occur with normal TCD results.
Collapse
Affiliation(s)
- Azza A G Tantawy
- Department of Pediatrics, Hematology-Oncology Unit, Ain Shams University, Cairo, Egypt
| | - Safaa W Ibrahim
- Department of Pediatrics, Hematology-Oncology Unit, Ain Shams University, Cairo, Egypt
| | | | - Amr N Rabie
- Department of Otorhinolaryngology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Sara M Makkeyah
- Department of Pediatrics, Hematology-Oncology Unit, Ain Shams University, Cairo, Egypt
| | - Iman A Ragab
- Department of Pediatrics, Hematology-Oncology Unit, Ain Shams University, Cairo, Egypt
| |
Collapse
|
4
|
Abdelmahmuod E, Yassin MA, Ahmed M, Ali E. The Relationship Between Sickle Cell Disease and Sudden Onset Sensorineural Deafness. Cureus 2020; 12:e9413. [PMID: 32864242 PMCID: PMC7449647 DOI: 10.7759/cureus.9413] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2020] [Accepted: 07/27/2020] [Indexed: 11/05/2022] Open
Abstract
Sickle cell anemia (SCA) is a hereditary hemoglobin (Hb) disorder associated with a very specific molecular lesion, which is the exchange of glutamic acid for valine in the sixth residue of the Hb beta chain, originating the S Hb. It is characterized by intermittent episodes of vascular occlusion and end-organ damage. Progressive organ damage may affect any organ with brain, eyes, pulmonary, hepatobiliary, spleen, genitourinary, and the musculoskeletal systems being the most commonly involved and reported. Other complications of the disease that have not been well described or studied include cranio-orbital syndromes, oropharyngeal syndromes, periodontal disease, and otologic syndromes. Considering the vaso-occlusive nature of sickle cell disease (SCD), the potential for auditory damage is not unexpected. However, the incidence of subjective hearing impairment among SCA is very low and and little is known about the relationship between SCA and hearing loss. Here we report a 43-year-old female with SCA who presented with sudden bilateral hearing loss and generalized body ache and admitted as a case of sensorineural deafness with vascular crisis; she received IV fluid and analgesia and improved after five days from the therapy.
Collapse
Affiliation(s)
| | | | - Mohanad Ahmed
- Internal Medicine, Hamad Medical Corporation, Doha, QAT
| | - Elrazi Ali
- Internal Medicine, Hamad Medical Corporation, Doha, QAT
| |
Collapse
|
5
|
Stuart A, Smith MR. The emergence and prevalence of hearing loss in children with homozygous sickle cell disease. Int J Pediatr Otorhinolaryngol 2019; 123:69-74. [PMID: 31075710 DOI: 10.1016/j.ijporl.2019.04.032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 03/16/2019] [Accepted: 04/19/2019] [Indexed: 10/27/2022]
Abstract
OBJECTIVES Many children with sickle cell disease (SCD) experience the effect of cochlear insult due to hemolytic anemia and vaso-occlusion that accompanies the disease. As a result, hearing sensitivity eventually decreases. The purpose of this study was to investigate the emergence of hearing loss and the prevalence of such in children with homozygous SCD. METHODS A large pediatric database was utilized to gather audiometric outcomes in children with homozygous SCD. Children were identified by primary diagnosis ICD codes. Demographic and audiometric data was drawn to determine presence, type, degree, and laterality of hearing loss. Hearing loss was defined as an elevated audiometric threshold >15 dB HL for pure tone air conduction audiometry or >20 dB HL minimal response level for sound-field testing. RESULTS One hundred and twenty-eight children were identified. The prevalence of hearing loss ranged from 28.8% to 50.8% depending on the calculation method (i.e., individual vs. ear specific prevalence and any elevated threshold vs. a three-frequency pure tone average). Conductive hearing loss and bilateral loss were most prevalent. The degree of hearing loss ranged from slight to profound. The mean age of identification of sensorineural hearing loss was 9.6 years. CONCLUSION The prevalence of hearing loss in children with homozygous SCD is higher than in normal children. Regular hearing assessments of children with SCD is warranted and should be advocated in early infancy and as part of their ongoing care.
Collapse
Affiliation(s)
- Andrew Stuart
- Department of Communication Sciences and Disorders, East Carolina University, Greenville, NC, USA.
| | - Madeline R Smith
- Department of Communication Sciences and Disorders, East Carolina University, Greenville, NC, USA
| |
Collapse
|
6
|
Abstract
This study sought to examine if modern medical evaluations including newborn screening and early diagnosis along with better methods of disease control have improved rates of hearing loss in children with sickle cell disease (SCD). Audiometric and medical data for patients with SCD was obtained from the AudGen Database and analyzed for the presence of hearing loss, type of hearing loss, severity of hearing loss, and correlation with comorbid conditions. Children with sickle cell trait (SCT) were used as a comparison group. A total of 189 patients with SCD and 244 patients with SCT had sufficient audiologic data available. Hearing loss was present in 62% of children with SCD and 50% of children with SCT in the study population. Patients with SCD were significantly more likely than those with SCT to have a sensorineural component to their hearing loss (P<0.001, odds ratio: 2.41 [1.53 to 3.79]) and to have severe or profound hearing loss (P=0.02, odds ratio: 4.00 [1.14 to 14.04]). The true prevalence of hearing loss in children with SCD has not been established as routine screening is not being performed. Routine auditory testing should be done for these children to detect this loss before it impacts development.
Collapse
|
7
|
Towerman AS, Hayashi SS, Hayashi RJ, Hulbert ML. Prevalence and nature of hearing loss in a cohort of children with sickle cell disease. Pediatr Blood Cancer 2019; 66:e27457. [PMID: 30207054 DOI: 10.1002/pbc.27457] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2018] [Revised: 08/16/2018] [Accepted: 08/20/2018] [Indexed: 11/10/2022]
Abstract
BACKGROUND Sickle cell disease (SCD) may cause injury to any organ, including the auditory system. Although the association of SCD and hearing loss has been described, the nature of this complication is unknown. We sought to establish the prevalence and nature of hearing loss in a referred cohort of children with SCD and to identify correlating disease- or treatment-associated factors. PROCEDURE We conducted a retrospective review of patients with SCD < 22 years of age who had hearing evaluations between August 1990 and December 2014. Demographics, audiograms, and disease and treatment variables were analyzed. RESULTS Two hundred and ten audiograms among 81 patients were reviewed, and 189 were evaluable. Seventy-two children constituted the referred cohort. Fourteen (19.4%) had hearing loss documented on at least one audiogram. Seven (9.7%) patients had only conductive hearing loss, and the loss persisted for up to 10.3 years. The median age of first identification was eight years. Six (8.3%) patients had hearing loss that was at least partially sensorineural. One patient's hearing loss was ambiguous. All sensorineural hearing losses were unilateral and 4/6 patients had prior documented normal hearing, indicating acquired loss. No correlations were identified. CONCLUSIONS Both conductive and sensorineural hearing losses are more prevalent in our study population than those observed in the general pediatric population. In children with SCD, sensorineural hearing loss appears to be acquired and unilateral. Conductive hearing loss was identified in older children and can persist. Serial screening is needed for early detection and more prompt intervention in this population.
Collapse
Affiliation(s)
- Alison S Towerman
- Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri
| | - Susan S Hayashi
- Department of Audiology, St. Louis Children's Hospital, St. Louis, Missouri
| | - Robert J Hayashi
- Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri
| | - Monica L Hulbert
- Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri
| |
Collapse
|
8
|
Bois E, Francois M, Benkerrou M, Van Den Abbeele T, Teissier N. Hearing loss in children with sickle cell disease: A prospective French cohort study. Pediatr Blood Cancer 2019; 66:e27468. [PMID: 30251366 DOI: 10.1002/pbc.27468] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2018] [Revised: 08/27/2018] [Accepted: 08/30/2018] [Indexed: 11/08/2022]
Abstract
BACKGROUND Sickle cell disease (SCD) is the most common genetic disease in France. In developing countries, it is associated with a high incidence of hearing loss. The aim of this study was to determine the prevalence of hearing loss in French children with SCD in order to determine if they need a close audiological follow-up. METHODS We performed a single-center prospective cross-sectional study of children with SCD. The children, without specific hearing symptom, underwent an ear, nose and throat examination with a hearing assessment between 2015 and 2016. RESULTS Eighty-nine children were included, aged from 5 to 19 years, with 73% of SS or Sβ0 genotype and 27% of SC or Sβ+ genotype. Ten children (11.2%) had hearing thresholds higher than 20 dB in at least one ear: one child with subnormal hearing, six otitis media with effusion (OME), and three sensorineural hearing loss. Late age at diagnosis of SCD, a high platelet count and a low hematocrit level were significantly associated with OME; moreover, children with OME had more severe clinical and biological characteristics than children with normal hearing. Furthermore, 12.4% of the children complained of tinnitus. The rate of sudden hearing loss was 2.2%. Finally, 7.1% of patients with normal hearing showed a speech discrimination disorder. CONCLUSIONS Several causes were identified for hearing loss in children with SCD. They therefore need a close audiological follow-up in order to avoid complications due to curable phenomena and to enable appropriate management for progressive complications.
Collapse
Affiliation(s)
- Emilie Bois
- Otolaryngology-Head and Neck Surgery Department, Robert Debré Hospital, Paris, France
| | - Martine Francois
- Otolaryngology-Head and Neck Surgery Department, Robert Debré Hospital, Paris, France
| | | | | | - Natacha Teissier
- Otolaryngology-Head and Neck Surgery Department, Robert Debré Hospital, Paris, France
| |
Collapse
|
9
|
Freitas NRBD, Pereira ND, Pessoa MS, Galvão F, Saad STO, Zanoni CT. Translation, and interobserver and test-retest reliability of the Brazilian Portuguese version of Children's Hospital Oakland Hip Evaluation Scale for patients with sickle cell disease. Hematol Transfus Cell Ther 2018; 40:226-232. [PMID: 31787155 PMCID: PMC6738485 DOI: 10.1016/j.htct.2018.01.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Revised: 01/19/2018] [Accepted: 01/24/2018] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND The Children's Hospital Oakland Hip Evaluation Scale is a disease-specific tool for the clinical and functional assessment of the hip in sickle cell disease. OBJECTIVES To translate the tool into Brazilian Portuguese and evaluate the interobserver and test-retest reliability. METHODS Eighteen patients diagnosed with sickle cell disease and a mean age of 49±11.9 years participated in the study. The scale was applied by two evaluators who did not speak to each other regarding their understanding of the tool and who had no prior training. Interobserver and test-retest reliability of individual items and of the total score were evaluated using the intraclass correlation coefficient and the Bland-Altman method. RESULTS When the overall score for each hip was considered, the test-retest intraclass correlation coefficient score for the right hip was 0.95 (0.89-0.98) and for the left hip it was 0.96 (0.91-0.98). Considering all assignments (total score), the score was 0.96 (0.90-0.98). The test-retest intraclass correlation coefficient varied from 0.76 to 1 for 18 of the 27 items (excellent) and from 0.53 to 0.75 for nine items (moderate). When the overall score for each hip was considered, the interobserver intraclass correlation coefficient for both hips was 0.94 (0.86-0.98). Considering all assignments, the total score was 0.94 (0.86-0.98). The interobserver intraclass correlation coefficient varied from 0.48 to 0.75 for 18 out of 27 items (moderate) and varied from 0.77 to 1 for the remaining nine items (excellent). CONCLUSION The results demonstrate that the Brazilian version of the Children's Hospital Oakland Hip Evaluation Scale presented adequate interobserver and test-retest reliability and that the version can be used to evaluate clinical function in sickle cell disease patients, producing consistent, standardized and reproducible results.
Collapse
Affiliation(s)
| | | | | | - Fábio Galvão
- Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
| | | | | |
Collapse
|
10
|
Rissatto-Lago MR, Salles C, Campos de Pinho FG, Menezes Lyra I, Terse-Ramos R, Teixeira R, Ladeia AM. Association between endothelial dysfunction and otoneurological symptoms in children with sickle cell disease. Hematology 2016; 22:299-303. [PMID: 27934541 DOI: 10.1080/10245332.2016.1261982] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
Abstract
OBJECTIVE To evaluate the association between endothelial dysfunction and otoneurological symptoms and vaso-occlusive phenomena in children with sickle cell disease (SCD). METHODS Cross-sectional study with 54 children, aged between 6 and19 years of age, of whom 28 had genotype SS and 26 apparently healthy (AA genotype) whose parents or guardians, or the children themselves, filled out a questionnaire designed to assess their otoneurological symptoms. All the individuals were submitted assessment of endothelial function by flow-mediated dilation (FMD) percentage with reactive hyperemia of brachial artery Doppler. RESULTS Otoneurological symptoms (tinnitus and/or vertigo) predominated in the SCD group (46.4 vs. 15.4%; p = 0.006). A negative correlation was observed between FMD percentage and time of evolution of vertigo SCD (r = -0.432; p = 0.022) and the linear regression analysis demonstrated that for every reduction in FMD percentage there was an increase in time of evolution of vertigo of 1.79 months (β = -1.79; p = 0.022). The positive correlation between episodes of painful crisis and time of evolution of vertigo (r = 0.3; p = 0.04). DISCUSSION The presence of vascular endothelial damage in the labyrinthine artery in patients with SCD is capable of compromising the semicircular canals, shown by clinical expression of otoneurological symptoms, such as vertigo. In the present study, an association was observed between endothelial dysfunction with otoneurological symptoms and otoneurological symptoms and vaso-occlusive phenomena in SCD.
Collapse
Affiliation(s)
- Mara Renata Rissatto-Lago
- a Bahiana School of Medicine and Public Health , Salvador , Brazil.,b Department of Life Science , State University of Bahia , Salvador , Brazil
| | - Cristina Salles
- a Bahiana School of Medicine and Public Health , Salvador , Brazil
| | | | - Isa Menezes Lyra
- c Federal University of Bahia, University Hospital Professor Edgar Santos-Pediatric Hematology , Salvador , Brazil
| | - Regina Terse-Ramos
- d Department of Pediatrics , School of Medicine of Bahia, Federal University of Bahia , Salvador , Brazil
| | - Rozana Teixeira
- a Bahiana School of Medicine and Public Health , Salvador , Brazil.,d Department of Pediatrics , School of Medicine of Bahia, Federal University of Bahia , Salvador , Brazil
| | | |
Collapse
|
11
|
Gualandro SFM, Fonseca GHH, Yokomizo IK, Gualandro DM, Suganuma LM. Cohort study of adult patients with haemoglobin SC disease: clinical characteristics and predictors of mortality. Br J Haematol 2015; 171:631-7. [PMID: 26255986 DOI: 10.1111/bjh.13625] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2015] [Accepted: 06/24/2015] [Indexed: 12/20/2022]
Abstract
Haemoglobin (Hb) SC disease is the second most common subtype of sickle cell disease and is potentially fatal. This study aimed to determine the clinical characteristics, outcome and predictors of mortality in HbSC disease patients, and to compare these findings with patients followed-up in different centres. Clinical, laboratory and outcome data were collected from a cohort of adult patients with HbSC disease followed between 1991 and 2103. Cox regression multivariate analysis was used to determine predictors of mortality. One hundred and fifty-five patients were followed-up over 20 years: 9% died and 70·8% had at least one complication. The most common complications were: painful crises (38·3%), retinopathy (33·8%), cholelithiasis (30·3%), osteonecrosis (24·8%) and sensorineural hearing disorders (9·7%). Frequency of chronic complications was similar in most studies. In multivariate analysis, hearing disorders remained an independent predictor of mortality (Odds Ratio 9·26, 95% confidence interval 1·1-74·8; P = 0·03). It was concluded that patients with HbSC disease receive a late diagnosis and there is remarkable similarity between the studies conducted in different centres around the world. Sensorineural hearing disorders were an independent predictor of mortality, suggesting that it may be useful to implement routine diagnostic screening.
Collapse
Affiliation(s)
- Sandra F Mm Gualandro
- Department of Haematology, University of São Paulo Medical School, São Paulo, Brazil
| | - Guilherme H H Fonseca
- Department of Haematology, University of São Paulo Medical School, São Paulo, Brazil
| | - Iara K Yokomizo
- Department of Haematology, University of São Paulo Medical School, São Paulo, Brazil
| | - Danielle M Gualandro
- Department of Cardiology, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
| | - Liliana M Suganuma
- Department of Haematology, University of São Paulo Medical School, São Paulo, Brazil
| |
Collapse
|
12
|
Kegele J, Hurth H, Lackner P, Enimil A, Sylverkin J, Ansong D, Nkyi C, Bonsu B, Agbenyega T, Schartinger VH, Schmutzhard E, Zorowka P, Kremsner P, Schmutzhard J. Otoacoustic emission testing in Ghanaian children with sickle-cell disease. Trop Med Int Health 2015; 20:1209-1212. [PMID: 25941122 DOI: 10.1111/tmi.12533] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To evaluate hearing loss in children as a complication of sickle-cell disease. METHODS In Kumasi, Ghana, 35 children with SCD aged 6 months to 10 years underwent transient-evoked otoacoustic emissions testing (TEOAE) to investigate the function of the inner ear. Healthy Ghanaian children recruited in school and kindergarten served as controls. RESULTS One of 35 children with SCD and 13 of 115 control children failed the otoacoustic emissions testing. This difference between the control group and the children with SCD was not statistically significant. CONCLUSION Early hearing impairment does not regularly occur in sickle-cell disease, and in children, it is not a likely cause of delayed or impaired language development.
Collapse
Affiliation(s)
- Josua Kegele
- Department of Neurology, NICU, Medical University Innsbruck, Innsbruck, Austria
| | - Helene Hurth
- Department of Neurology, NICU, Medical University Innsbruck, Innsbruck, Austria
| | - Peter Lackner
- Department of Neurology, NICU, Medical University Innsbruck, Innsbruck, Austria
| | - Anthony Enimil
- Komfo Anokye Teaching Hospital & Kwama Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Justice Sylverkin
- Komfo Anokye Teaching Hospital & Kwama Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Daniel Ansong
- Komfo Anokye Teaching Hospital & Kwama Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Clara Nkyi
- Komfo Anokye Teaching Hospital & Kwama Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Benedicta Bonsu
- Komfo Anokye Teaching Hospital & Kwama Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Tsiri Agbenyega
- Komfo Anokye Teaching Hospital & Kwama Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Volker H Schartinger
- Department of Otorhinolaryngology, Medical University Innsbruck, Innsbruck, Austria
| | - Erich Schmutzhard
- Department of Neurology, NICU, Medical University Innsbruck, Innsbruck, Austria
| | - Patrick Zorowka
- Department of Hearing, Speech and Voice Disorders, Medical University Innsbruck, Innsbruck, Austria
| | - Peter Kremsner
- Institut für Tropenmedizin, Eberhard Karls Universität Tübingen, Tübingen, Germany
| | - Joachim Schmutzhard
- Department of Otorhinolaryngology, Medical University Innsbruck, Innsbruck, Austria
| |
Collapse
|
13
|
Silva LPAD, Nova CV, Lucena R. Sickle cell anemia and hearing loss among children and youngsters: literature review. Braz J Otorhinolaryngol 2012; 78:126-31. [PMID: 22392250 PMCID: PMC9443893 DOI: 10.1590/s1808-86942012000100020] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2009] [Accepted: 11/08/2009] [Indexed: 11/22/2022] Open
Abstract
Sickle cell anemia is still a significant public health issue in underdeveloped and developing countries. Sickle cell disease is one of the most common inherited diseases in Brazil. It affects mainly the mixed race population. Approximately 1 African-Brazilian child is affected with sickle cell disease for every 37,400 children born alive. Hearing loss has been considered one of the main clinical manifestations, especially in children. However, to date, there are just a hand full of studies in Brazil and the Brazilian state of Bahia has the largest African-descended population, attempting to establish the frequency of this event. Objectives To analyze the major studies associated with the subject, published in the last twenty years in the main indexed databases. Methods To use MEDLINE to identify the main papers published in English in medical literature, between January of 1989 and January of 2009; associating sickle cell anemia and hearing loss, with its clinical outcomes. Conclusion Given that it is always possible to attempt to prevent disabilities, understanding hearing loss in children with sickle cell anemia enables to maximize quality of life and provides for a broader school attendance.
Collapse
|
14
|
Contralateral Suppression of Transient-Evoked Otoacoustic Emissions in Children With Sickle Cell Disease. Ear Hear 2012; 33:421-9. [DOI: 10.1097/aud.0b013e31823effd9] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
15
|
Lionnet F, Hammoudi N, Stojanovic KS, Avellino V, Grateau G, Girot R, Haymann JP. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 2012; 97:1136-41. [PMID: 22315500 DOI: 10.3324/haematol.2011.055202] [Citation(s) in RCA: 97] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
BACKGROUND Hemoglobin sickle cell disease is one of the most frequent hemoglobinopathies. Surprisingly, few studies have been dedicated to this disease, currently considered to be a mild variant of homozygous sickle cell disease. The aim of this study was to update our knowledge about hemoglobin sickle cell disease. DESIGN AND METHODS The study involved a single center series of 179 patients. Clinical and biological data were collected with special attention to the assessment of pulmonary arterial hypertension and nephropathy. RESULTS Hemoglobin sickle cell diagnosis was delayed and performed in adulthood in 29% of cases. Prevalence of hospitalized painful vasoocclusive crisis, acute chest syndrome and priapism was 36%, 20% and 20%, respectively. The most common chronic organ complications were retinopathy and sensorineural otological disorders in 70% and 29% of cases. Indeed, prevalence of complications reported in homozygous sickle cell disease, such as nephropathy, suspicion of pulmonary hypertension, strokes and leg ulcers was rather low (13%, 4% and 1%, respectively). Phlebotomy performed in 36% of this population (baseline hemoglobin 11.5 g/dL) prevented recurrence of acute events in 71% of cases. CONCLUSIONS Our data suggest that hemoglobin sickle cell disease should not be considered as a mild form of sickle cell anemia but as a separate disease with a special emphasis on viscosity-associated otological and ophthalmological disorders, and with a low prevalence of vasculopathy (strokes, pulmonary hypertension, ulcers and nephropathy). Phlebotomy was useful in reducing acute events and a wider use of this procedure should be further investigated.
Collapse
|
16
|
Alkindi S, Arafa N, Al Okbi M, Pathare A. Complete recovery following sudden sensorineural hearing loss in a patient with sickle cell disease. Hematol Oncol Stem Cell Ther 2011; 4:97-9. [DOI: 10.5144/1658-3876.2011.97] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
17
|
Okbi MHA, Alkindi S, Al Abri RK, Mathew J, Nagwa AA, Pathare AV. Sensorineural hearing loss in sickle cell disease-A prospective study from Oman. Laryngoscope 2011; 121:392-6. [DOI: 10.1002/lary.21374] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
18
|
de Castro Silva IM, Magalhães IQ, Toscano RA, Gandolfi L, Pratesi R. Auditory-evoked response analysis in Brazilian patients with sickle cell disease. Int J Audiol 2010; 49:272-6. [DOI: 10.3109/14992020903321742] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
19
|
Runel-Belliard C, Lesprit E, Quinet B, Wiener-Vacher S, Saizou C, Grimprel E. [Vestibular neuronitis in a teenager with sickle cell disease. Treatment is urgent]. Arch Pediatr 2008; 15:1423-5. [PMID: 18675541 DOI: 10.1016/j.arcped.2008.06.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2007] [Revised: 04/30/2008] [Accepted: 06/18/2008] [Indexed: 11/26/2022]
Abstract
Vestibular syndrome is not frequently described in patients with sickle cell disease. We report the case of a teenager with sickle cell disease who had a vestibular syndrome with vertigo that successfully responded to exchange transfusion. We discuss guidelines and review the literature in view of this case report. Sensorineural disorders should be considered as stroke syndromes. They require urgent treatment consisting of exchange transfusion or maintaining optimal hydration associated with blood withdrawal. Treatment of vestibular syndrome in sickle cell disease is urgent.
Collapse
Affiliation(s)
- C Runel-Belliard
- Centre de la drépanocytose, hôpital Armand-Trousseau, 26, avenue du Docteur-Arnold-Netter, 75012 Paris, France.
| | | | | | | | | | | |
Collapse
|